FI960367L - Nya dialkoxipyridinylbenzimidazolderivat - Google Patents

Nya dialkoxipyridinylbenzimidazolderivat Download PDF

Info

Publication number
FI960367L
FI960367L FI960367A FI960367A FI960367L FI 960367 L FI960367 L FI 960367L FI 960367 A FI960367 A FI 960367A FI 960367 A FI960367 A FI 960367A FI 960367 L FI960367 L FI 960367L
Authority
FI
Finland
Prior art keywords
dialkoxypyridinylbenzimidazole
derivatives
new
new dialkoxypyridinylbenzimidazole
dialkoxypyridinylbenzimidazole derivatives
Prior art date
Application number
FI960367A
Other languages
English (en)
Finnish (fi)
Other versions
FI960367A7 (sv
FI960367A0 (sv
Inventor
Per Lennart Lindberg
Gunnel Elisabeth Sunden
Unge Pet Oskar Sverker Von
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI960367L publication Critical patent/FI960367L/sv
Publication of FI960367A7 publication Critical patent/FI960367A7/sv
Publication of FI960367A0 publication Critical patent/FI960367A0/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI960367A 1994-05-27 1995-05-11 Nya dialkoxipyridinylbenzimidazolderivat FI960367A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9400511 1994-05-27
PCT/SE1995/000519 WO1995032959A1 (en) 1994-05-27 1995-05-11 Novel dialkoxy-pyridinyl-benzimidazole derivatives

Publications (3)

Publication Number Publication Date
FI960367L true FI960367L (sv) 1996-01-26
FI960367A7 FI960367A7 (sv) 1996-01-26
FI960367A0 FI960367A0 (sv) 1996-01-26

Family

ID=20392945

Family Applications (1)

Application Number Title Priority Date Filing Date
FI960367A FI960367A0 (sv) 1994-05-27 1995-05-11 Nya dialkoxipyridinylbenzimidazolderivat

Country Status (18)

Country Link
EP (1) EP0712401A1 (sv)
JP (1) JPH09504557A (sv)
CN (1) CN1128997A (sv)
AU (1) AU2633095A (sv)
BR (1) BR9506235A (sv)
CA (1) CA2166988A1 (sv)
CZ (1) CZ24396A3 (sv)
EE (1) EE9600011A (sv)
FI (1) FI960367A0 (sv)
HU (1) HU9600005D0 (sv)
IL (1) IL113604A0 (sv)
IS (1) IS4321A (sv)
MA (1) MA23563A1 (sv)
NO (1) NO960268D0 (sv)
PL (1) PL312692A1 (sv)
TN (1) TNSN95062A1 (sv)
WO (1) WO1995032959A1 (sv)
ZA (1) ZA954125B (sv)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9423968D0 (en) * 1994-11-28 1995-01-11 Astra Ab Resolution
GB9423970D0 (en) * 1994-11-28 1995-01-11 Astra Ab Oxidation
US6489346B1 (en) 1996-01-04 2002-12-03 The Curators Of The University Of Missouri Substituted benzimidazole dosage forms and method of using same
US5840737A (en) 1996-01-04 1998-11-24 The Curators Of The University Of Missouri Omeprazole solution and method for using same
BR9915421A (pt) * 1998-11-18 2001-08-07 Astrazeneca Ab Processo para a fabricação de sais alcalinos levemente solúveis ou menos solúveis de heterociclos de sulfinila substituìda, forma de dosagem farmacêutica, uso da mesma, método de tratamento de doenças gastrointestinais, e, processo para a fabricação de uma forma de dosagem farmacêutica.
US8206741B2 (en) 2001-06-01 2012-06-26 Pozen Inc. Pharmaceutical compositions for the coordinated delivery of NSAIDs
US8993599B2 (en) 2003-07-18 2015-03-31 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
US8906940B2 (en) 2004-05-25 2014-12-09 Santarus, Inc. Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
MX2009004475A (es) 2006-10-27 2009-08-12 Univ Missouri Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
US8247440B2 (en) 2008-02-20 2012-08-21 Curators Of The University Of Missouri Composition comprising omeprazole, lansoprazole and at least one buffering agent
BRPI0918492A2 (pt) 2008-09-09 2015-12-01 Astrazeneca Ab uso de naproxen, ou sal farmaceuticamente aceitável do mesmo, e esomeprazol, ou sal farmaceuticamente aceitável do mesmo
EP2445499A4 (en) 2009-06-25 2013-02-27 Astrazeneca Ab METHOD FOR TREATING A PATIENT WITH RISK OF DEVELOPING A NSAID-ASSOCIATED SPURGE
CA2860231A1 (en) 2011-12-28 2013-07-04 Pozen Inc. Improved compositions and methods for delivery of omeprazole plus acetylsalicylic acid

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL165898B1 (pl) * 1990-06-20 1995-02-28 Astra Ab Sposób wytwarzania nowych pochodnych dwualkoksyplrydynylobenzlmldazolu PL
DE4035455A1 (de) * 1990-11-08 1992-05-14 Byk Gulden Lomberg Chem Fab Enantiomerentrennung

Also Published As

Publication number Publication date
JPH09504557A (ja) 1997-05-06
NO960268L (no) 1996-01-23
FI960367A7 (sv) 1996-01-26
PL312692A1 (en) 1996-05-13
CA2166988A1 (en) 1995-12-07
FI960367A0 (sv) 1996-01-26
HU9600005D0 (en) 1996-03-28
CZ24396A3 (en) 1996-06-12
AU2633095A (en) 1995-12-21
BR9506235A (pt) 1997-08-12
TNSN95062A1 (fr) 1996-02-06
WO1995032959A1 (en) 1995-12-07
MA23563A1 (fr) 1995-12-31
IS4321A (is) 1996-01-17
EP0712401A1 (en) 1996-05-22
CN1128997A (zh) 1996-08-14
NO960268D0 (no) 1996-01-23
IL113604A0 (en) 1995-08-31
ZA954125B (en) 1995-11-27
EE9600011A (et) 1996-04-15

Similar Documents

Publication Publication Date Title
FI954829L (sv) Aroylpiperidinderivat
NO952854D0 (no) 1-arylpyrimidin-derivater
DE59508427D1 (de) 3-aryl-4-hydroxy-delta 3 -dihydrothiophenon-derivate
FI972194A7 (sv) Nya benzylpyrimidiner
DE69735712D1 (de) Aryl-pyrimidin-derivate
ATE261942T1 (de) 6-phenylpyridinderivate
IS4800A (is) Nýjar 19-nor-pregnene afleiður
EP0708091A3 (en) Indoloyl-guanidines derivatives
DE69732576D1 (de) Tetrahydrobenzindolon-derivate
DE69430587D1 (de) Pyrimidin-acyclonukleosid-derivate
FI953710L (sv) Nya pyrrolokarbazoler
BR9509793A (pt) Derivados de tiofeneno
FI971227A7 (sv) Pyramidinylpyrazolderivat
FI960367A7 (sv) Nya dialkoxipyridinylbenzimidazolderivat
EE9900182A (et) 2-metoksüfenüülpiperasiini derivaadid
DE69527786D1 (de) Diaminomethyliden-derivate
FI964853L (sv) Deacetoxitaxolderivat
NO970144L (no) Trifluormetylkinolinkarboksylsyre-derivat
DE59509209D1 (de) Diphenyloxazolin-derivate
DE69510792D1 (de) Naphtochinonderivate
FI955026L (sv) Alkyl-5-metylfonylbensoylguanidinderivat
BR9509877A (pt) Novos derivados de pirimidinilóxi-e piridimidinilamino- etilfenil-dioxolano
FI965181A7 (sv) Polyalkohol-peptidderivat
FI963122L (sv) Karbamoylmetylureaderivat
BR9506613A (pt) Derivados de feniltio-oxazolinas

Legal Events

Date Code Title Description
FD Application lapsed